Actively Recruiting
Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
Led by University of Maryland, Baltimore · Updated on 2025-09-22
5
Participants Needed
1
Research Sites
385 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to examine the safety and feasibility of performing hyperpolarized metabolic MRI in the diagnosis of brain tumor. This study will also assess the accuracy of hyperpolarized metabolic MRI to diagnose intermediate to patients with infiltrating gliomas and examine the added utility of metabolic MRI over standard MRI imaging The FDA is allowing the use of hyperpolarized \[1-13C\] pyruvate (HP 13C-pyruvate) in this study. Up to 5 patients may take part in this study at the University of Maryland, Baltimore (UMB).
CONDITIONS
Official Title
Hyperpolarized 13C-pyruvate Metabolic MRI With Infiltrating Gliomas
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a new brain lesion suspected to be infiltrating gliomas or with prior history of infiltrating glioma scheduled for tumor biopsy or resection
- Age between 18 and 80 years
- Able to undergo contrast-enhanced MRI
- Negative serum pregnancy test
You will not qualify if you...
- Unable to undergo MRI scan
- Unable to receive IV contrast due to severe reaction or kidney problems
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Rosy Njonkou Tchoquessi
Baltimore, Maryland, United States, 21201
Actively Recruiting
Research Team
R
Rosy Njonkou Tchoquessi
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here